Related Experiment Video
Updated: Aug 12, 2026
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Beta blockade to prevent atrial dysrhythmias following coronary bypass surgery
D L Paull1, S L Tidwell, S W Guyton
1Section of Cardiothoracic Surgery, Virginia Mason Medical Center, Seattle, Washington, USA.
Insights
Metoprolol did not prevent post-CABG atrial fibrillation (AF) even with dose titration. A new cardioplegia technique, not the drug, likely reduced AF incidence in coronary artery bypass graft patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Atrial fibrillation (AF) and atrial flutter are common complications after coronary artery bypass grafting (CABG).
- Existing studies on beta-blocker prophylaxis for post-CABG AF have yielded inconsistent results.
- Preventing AF after CABG is crucial to reduce hospital stay and morbidity.
Purpose of the Study:
- To evaluate the efficacy of metoprolol in preventing post-CABG AF.
- To determine if a dosing algorithm achieving beta-adrenergic blockade improves AF prevention.
- To assess the impact of a continuous cardioplegia technique on AF rates.
Main Methods:
- A randomized, placebo-controlled trial involving 100 patients undergoing CABG.
- Patients received either metoprolol or placebo post-surgery.
- A dosing algorithm was employed to achieve targeted beta-adrenergic blockade.
Main Results:
- No significant difference in AF incidence between the metoprolol (24%) and placebo (26%) groups.
- Overall AF incidence in the institution decreased from 31% to 23% during the study period.
- This reduction correlated with the implementation of a continuous cardioplegia delivery technique.
Conclusions:
- Metoprolol is ineffective for preventing post-CABG AF, even with dose titration.
- The observed decrease in AF incidence is likely attributable to the adoption of continuous cardioplegia.
- Further research may be needed to explore alternative AF prevention strategies in CABG patients.
Background:
Atrial fibrillation and atrial flutter (AF) frequently complicate coronary artery bypass surgery (CABG) and increase hospital stay as well as morbidity. Studies of drug prophylaxis to prevent AF with beta-adrenergic blocking agents administered in fixed doses have had conflicting results.
Methods:
One hundred patients were randomized to receive metoprolol or placebo following CABG. A dosing algorithm was used to achieve clinically significant beta-adrenergic blockade.
Results:
There was no significant difference between the incidence of AF in the metoprolol (24%) and placebo (26%) groups. However, the incidence of AF in all patients having CABG at this institution declined over the period of the study from 31% to 23% (P < .025), in association with the adoption of a continuous technique of cardioplegia delivery.
Conclusions:
Metoprolol is not efficacious for the prevention of post-CABG AF even when dosage is titrated to achieve clinical evidence of beta blockade. It is likely that the adoption of a continuous cardioplegia technique caused a reduction in our incidence of post-CABG AF.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:22Heart Failure Drugs: β-Blockers
01:27Coronary Artery Disease V: Interprofessional Care
01:25Dysrhythmias VI: Management of Dysrhythmias